These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 10640290)
21. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat]. Pu SF; Han JS Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670 [TBL] [Abstract][Full Text] [Related]
22. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro. Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560 [TBL] [Abstract][Full Text] [Related]
23. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy. Idänpään-Heikkilä JJ; Guilbaud G; Kayser V J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848 [TBL] [Abstract][Full Text] [Related]
24. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze. Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473 [TBL] [Abstract][Full Text] [Related]
25. The enhancement of morphine antinociception by a CCKB receptor antagonist in the rat depends on the phase of inflammation and the intensity of carrageenin-induced hyperalgesia. Perrot S; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V Pain; 1998 Feb; 74(2-3):269-74. PubMed ID: 9520241 [TBL] [Abstract][Full Text] [Related]
26. Anti-analgesia and reduced antinociception from supraspinally administered beta-endorphin in stressed rats: dependence on spinal cholecystokinin via cholecystokinin B receptors. Hawranko AA; Serafini M; Smith DJ Neurosci Lett; 1999 May; 267(2):101-4. PubMed ID: 10400222 [TBL] [Abstract][Full Text] [Related]
27. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats. Wen D; Sun D; Zang G; Hao L; Liu X; Yu F; Ma C; Cong B Neuroscience; 2014 Sep; 277():14-25. PubMed ID: 24993476 [TBL] [Abstract][Full Text] [Related]
28. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by oxytocin in ovariectomized rats. Wu CL; Doong ML; Wang PS Eur J Pharmacol; 2008 Feb; 580(3):407-15. PubMed ID: 18078924 [TBL] [Abstract][Full Text] [Related]
29. Involvement of cholecystokinin receptor in the inhibition of gastrointestinal motility by estradiol in ovariectomized rats. Wu CL; Hung CR; Chang FY; Pau KY; Wang PS Scand J Gastroenterol; 2002 Oct; 37(10):1133-9. PubMed ID: 12408516 [TBL] [Abstract][Full Text] [Related]
30. Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats. Lu L; Huang M; Ma L; Li J Behav Brain Res; 2001 Apr; 120(1):105-10. PubMed ID: 11173090 [TBL] [Abstract][Full Text] [Related]
31. Association of the peptidase inhibitor RB 101 and a CCK-B antagonist strongly enhances antinociceptive responses. Maldonado R; Derrien M; Noble F; Roques BP Neuroreport; 1993 Jul; 4(7):947-50. PubMed ID: 8369487 [TBL] [Abstract][Full Text] [Related]
32. Effects of caerulein and CCK antagonists on tolerance induced to morphine antinociception in mice. Zarrindast MR; Zabihi A; Rezayat M; Rakhshandeh H; Ghazi-Khansari M; Hosseini R Pharmacol Biochem Behav; 1997 Sep; 58(1):173-8. PubMed ID: 9264087 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats. Wu CL; Hung CR; Chang FY; Pau KY; Wang PS Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):406-13. PubMed ID: 12690433 [TBL] [Abstract][Full Text] [Related]
34. Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain. Joshi SK; Mikusa JP; Weaver B; Honore P J Pain; 2008 Feb; 9(2):146-56. PubMed ID: 18088559 [TBL] [Abstract][Full Text] [Related]
35. The CCK-B receptor antagonist Cl 988 reverses tolerance to morphine in rats. Hoffmann O; Wiesenfeld-Hallin Z Neuroreport; 1994 Dec; 5(18):2565-8. PubMed ID: 7696605 [TBL] [Abstract][Full Text] [Related]
36. Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats. Torres-López JE; Juárez-Rojop IE; Granados-Soto V; Diaz-Zagoya JC; Flores-Murrieta FJ; Ortíz-López JU; Cruz-Vera J Neuropharmacology; 2007 Mar; 52(3):788-95. PubMed ID: 17157334 [TBL] [Abstract][Full Text] [Related]
37. Role of TRPV1 and TRPA1 in visceral hypersensitivity to colorectal distension during experimental colitis in rats. Vermeulen W; De Man JG; De Schepper HU; Bult H; Moreels TG; Pelckmans PA; De Winter BY Eur J Pharmacol; 2013 Jan; 698(1-3):404-12. PubMed ID: 23099257 [TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. Lu L; Huang M; Liu Z; Ma L Neuroreport; 2000 Mar; 11(4):829-32. PubMed ID: 10757528 [TBL] [Abstract][Full Text] [Related]
39. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats. Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211 [TBL] [Abstract][Full Text] [Related]
40. Effects of kappa opioids in the inflamed rat colon. Sengupta JN; Snider A; Su X; Gebhart GF Pain; 1999 Feb; 79(2-3):175-85. PubMed ID: 10068163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]